Genfit Competitors and Similar CompaniesClear all

Genfit's competitors and similar companies include Ablynx, Promethera Biosciences and Roche.
Genfit
Genfit
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
Ablynx
Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
Promethera Biosciences
Promethera Biosciences
Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases.
Roche
Roche
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
Founding Date
Founding Date
1999
Founding Date
2001
Founding Date
2009
Founding Date
1896
Type
Type
Public
Type
Subsidiary
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Loos, FR HQ
Cambridge, US
Locations
Gent, BE HQ
Locations
Mont-Saint-Guibert, BE HQ
Charleroi, BE
Ganshoren, BE
Chuo City, JP
Chuo City, JP
Basel, CH
Durham, US
see more
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
North Ryde, AU
Sydney, AU
Wien, AT
Dhaka, BD
see more
Employees
Employees
180
Employees
1252% decrease
Employees
185% decrease
Employees
103,249

Financial

Revenue (est.)
Revenue (est.)
€65.4m (FY, 2025)
Revenue (est.)
€85.2m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
CHF61.5b (FY, 2025)
Cost of goods
Cost of goods
€302k (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
CHF13.1b (FY, 2025)
Gross profit
Gross profit
€70.8m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Gross profit
CHF50.5b (FY, 2025)
Net income
Net income
(€86m) (FY, 2025)
Net income
(€1.1m) (FY, 2016)
Net income
N/A
Net income
CHF13.8b (FY, 2025)

Operating

Patents (Foreign)
Patents (Foreign)
450 (FY, 2019)
Patents (Foreign)
180 (Q2, 2017)
Patents (Foreign)
N/A
Patents (Foreign)
N/A
Patents (US)
Patents (US)
28 (FY, 2019)
Patents (US)
50 (Q2, 2017)
Patents (US)
N/A
Patents (US)
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 498.8m
Total funding raised
$ 146m
Total funding raised
$ 7.8b
For sources of this data, please see the company profile

View Company Profiles

Ablynx
HQ
Gent, BE

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.

View company
Promethera Biosciences
HQ
Mont-Saint-Guibert, BE

Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases.

View company
Roche
HQ
Basel, CH
Employees
103,249

Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.

View company